EGFR and neoplasm: Immunohistochemical analysis showed that MGG70R (pre-dacomitinib tumour) had diffuse and intense immunopositivity for EGFR and its activated form phospho-EGFR, a very similar staining pattern to that observed in the original tumour MGG70 (Fig. 2, Supplementary Fig. S1).